VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/30/13 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the "Company") is pleased to provide an update on the Resonance® carinata growing program currently being conducted by its majority-owned subsidiary, Agrisoma Biosciences Inc. ("Agrisoma").
The 2013 growing program was introduced on March 26, 2013, at a day-long event held in Swift Current, Saskatchewan, in connection with the Government of Saskatchewan's Ministry of Agriculture, the Saskatchewan Mustard Development Commission, and Prairie Gold. The presentation covered a range of topics of interest to potential growers, including agronomics, Resonance® carinata breeding and varieties, crop inputs (fertilizer, weed & insect control), crop insurance, and grower experiences from last year.
The 2013 contracting program is in progress. Spring has been colder and longer than normal this year. Farmers in Alberta, Saskatchewan and Manitoba usually begin planting in late April in southern areas, but 2013 planting has been delayed for many growers. The delayed planting season and resulting shortened growing season is not expected to impact the ability of growers to successfully cultivate Resonance® carinata in the current year. A further update will be provided when the growing season progresses.
Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) is an agricultural technology company focused on renewable fuels including biojet and biodiesel. Calyx's majority-owned operating subsidiary, Agrisoma Biosciences Inc., is producing a new proprietary non-food energy feedstock crop, Resonance® carinata, which yields oil that can be refined into fuels that work in existing engines as a 100 percent petroleum substitute. From seed to sky, fuels produced from Resonance® carinata substantially reduce carbon and other harmful emissions, and help to reduce global petroleum dependence. For further information about Calyx, please visit www.calyxbio.com.
Forward-Looking Statements: This document contains certain forward-looking statements concerning Calyx and/or Agrisoma, as well as other expectations, plans, goals, objectives, information or statements about future events, conditions, results of operations or performance that may constitute "forward-looking statements" or "forward-looking information" under applicable securities legislation. Such statements or information involve substantial known and unknown risks and uncertainties, certain of which are beyond Calyx's and/or Agrisoma's control, including general business, economic, competitive, political and social uncertainties; the delay or failure to receive regulatory approvals, the characteristics and viability for bio-fuel development, the willingness of third parties to conclude agreements with Calyx and/or Agrisoma on terms that are acceptable to management of Calyx and/or Agrisoma, and the ability of Calyx and/or Agrisoma to secure sufficient future funding to carry out all of its business plans.
Such forward-looking statements or information are based on a number of assumptions, which may prove to be incorrect. In addition to other assumptions identified in this news release, assumptions have been made regarding, among other things, commodity prices, operating conditions, capital and other expenditures, and project development activities.
Although Calyx and/or Agrisoma believes that the expectations reflected in such forward-looking statements or information are reasonable, undue reliance should not be placed on forward-looking statements because Calyx and/or Agrisoma can give no assurance that such expectations will prove to be correct. Forward-looking statements or information are based on current expectations, estimates and projections that involve a number of risks and uncertainties which could cause actual results to differ materially from those anticipated by Calyx and/or Agrisoma and described in the forward-looking statements or information.
The forward-looking statements or information contained in this news release are made as of the date hereof and Calyx and/or Agrisoma undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise unless so required by applicable securities laws or the TSX Venture Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
This press release shall not constitute an offer to sell, nor the solicitation of an offer to buy, any securities in the United States, nor shall there be any sale of securities mentioned in this press release in any state in the United States in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Calyx Bio-Ventures Inc.
W. Hugh Notman
President & CEO
Calyx Bio-Ventures Inc.
Most Popular Stories
- Apple Wants Samsung to Pay $22M for Patent Dispute Legal Bills
- Twitter Coming to Phones Without Internet
- NASA Fellowships, Scholarships Bring Diversity to Workforce
- Dish Network Leads 2013 Top 50 Advertisers List
- Networks Vie for U.S. Hispanic TV Viewers
- Ad Counts Rise in 2013 for Hispanic Magazines
- Entravision Initiates Quarterly Cash Dividend
- Jobs Report Brings Cheer As Unemployment Drops to Five-year Low
- Warner Bros. Unleashes 'Hobbit: Desolation of Smaug' Merchandise
- Shanghai Smog Forces Factory Shutdowns